To speed up approvals for Pfizer and Moderna in India, the government may grant them indemnity from liability. Health Ministry sources have said other countries have done it and “there is no problem” in granting indemnity or legal protection from any claims linked to the use of a company’s COVID-19 vaccine. In another key waiver, the drug regulator has done away with the requirement of India-specific trials for foreign vaccines approved by specific countries and WHO for emergency use. Experts explain what this means for India’s vaccination program.
About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe to our channels:
NDTV India (Hindi News): https://www.youtube.com/user/ndtvindia?sub_confirmation=1
Follow us on Social Media:
Like us on Facebook: https://www.facebook.com/ndtv/
Follow us on Twitter: https://twitter.com/ndtv/
Follow us on Instagram: https://www.instagram.com/ndtv/
Join NDTV on Telegram Messenger: https://t.me/NDTVbot/?start=hi
Follow us on Google News for Breaking and Latest News Updates:
NDTV India (Hindi News): https://bit.ly/3mNVwMY
Download NDTV Mobile Apps:
Watch More Videos: